Search

everythinglearnresearchcommunity

for

Search:↓

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

The two lotions used day and night may be a good alternative to minoxidil for hair loss treatment with better cosmetic effects and tolerance.

Stress hormone CRF causes hair loss and inhibits hair growth in human cells.

Adrenocortical extract is less effective at stopping hair growth in young rats than in adult rats.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

Artemis dysfunction might cause hair loss through telomere shortening.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

The document suggests that drugs for prostate issues might cause lasting sexual, mental, and physical health problems due to blood vessel damage in the penis.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Corticosterone makes ethanol more effective at blocking brain processes important for learning and memory.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

A rare type of skin cancer on the scalp can be mistaken for hair loss, causing delayed diagnosis and severe damage.

The document concludes that various topical medications are effective for skin conditions but often cause skin irritation as a side effect.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.